Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...
This week, our reader is finding their feet in a new job while paying off a car loan and saving for a mortgage.
After a pair of impressive wins in the Players Era men's championship, No. 17 Tennessee makes the trip to upstate New York to meet Syracuse in the ACC/SEC Challenge on ...